Treatment: Vaccines/drugs in the pipeline for COVID-19
Chloroquine approved for emergency use by US FDA The US Food and Drug Administration (FDA) approved limited emergency use for ...
Chloroquine approved for emergency use by US FDA The US Food and Drug Administration (FDA) approved limited emergency use for ...
I-Mab Biopharma is developed TJM2, a neutralising antibody, as a treatment for cytokine storm in patients suffering from a severe case of coronavirus infection. The drug targets the human granulocyte-macrophage colony-stimulating factor (GM-CSF), which is responsible for acute and chronic inflammation.
The company will commence development after receiving approval for the Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA).